Dynamic Medical Technologies (ROCO:4138) ROCE %: 9.76% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4138 Dynamic Medical Technologies Inc ROCO:4138
78 GF Score
Price NT$50.90
GF Value NT$74.17
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dynamic Medical Technologies ROCE %?

Dynamic Medical Technologies ROCO:4138 +0.39% 78 ROCE % is 9.76% as of Dec. 2025. GuruFocus rates ROCO:4138 with a GF Score™ of 78/100 and a GF Value™ of NT$74.17 (Significantly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dynamic Medical Technologies's annualized ROCE % for the quarter that ended in Dec. 2025 was 9.76%.

Dynamic Medical Technologies  (ROCO:4138) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dynamic Medical Technologies ROCE % Related Terms

Dynamic Medical Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Dynamic Medical Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynamic Medical Technologies ROCE % Chart

Dynamic Medical Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.82 10.42 15.77 14.28 10.14

Dynamic Medical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.38 11.52 11.03 10.09 9.76
ROCO:4138
78GF Score
Dynamic Medical Technologies Inc ROCO:4138
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dynamic Medical Technologies ROCE % Calculation

Dynamic Medical Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=222.638/( ( (3004.341 - 869.163) + (3126.647 - 869.772) )/ 2 )
=222.638/( (2135.178+2256.875)/ 2 )
=222.638/2196.0265
=10.14 %

Dynamic Medical Technologies's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=216.784/( ( (2978.317 - 792.051) + (3126.647 - 869.772) )/ 2 )
=216.784/( ( 2186.266 + 2256.875 )/ 2 )
=216.784/2221.5705
=9.76 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.76% mean?
Dynamic Medical Technologies (ROCO:4138) has a ROCE % of 9.76% as of Dec. 2025.
Is Dynamic Medical Technologies' ROCE % too high?
Dynamic Medical Technologies' current ROCE % is 9.76%. The Medical Devices & Instruments industry median ROCE % is 2.26. Dynamic Medical Technologies' value of 9.76% is 331.9% above this industry median. Overall, Dynamic Medical Technologies has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' ROCE % compare to ABT and SYK?
Dynamic Medical Technologies' ROCE % of 9.76% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.26. Dynamic Medical Technologies' value of 9.76% is 331.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.26, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamic Medical Technologies's current ROCE % of 9.76% is 331.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamic Medical Technologies's current ROCE % is 9.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.17, compared to a current price of NT$50.90 — trading 31.4% below its estimated fair value. The current ROCE % is 9.76% and 331.9% above the Medical Devices & Instruments industry median of 2.26. Dynamic Medical Technologies' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current ROCE % is 9.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?

Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued. The current stock price of NT$50.90 is trading 31.4% below its estimated GF Value™ of NT$74.17. GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4138:

  • ROCE %: 9.76%
  • GF Value™: NT$74.17 vs. price of NT$50.90 (31.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs
  • Industry Position: 331.9% above the Medical Devices & Instruments median

No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dynamic Medical Technologies Business Description

Address No. 880, Zhongzheng Road, 14th Floor, Zhonghe District, New Taipei City, TWN, 23586
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
78GF Score

Get the complete analysis for ROCO:4138

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.90
Price
NT$74.17
GF Value